Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEPPER trial of progesterone to prevent preterm birth in women with placenta previa
2023-507763-18-01Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of progesterone in placenta previa (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Number of preterm births before 37 weeks of gestation. Planned start May 2024; status: authorised.
02
Drugs
progesterone
03
Conditions
placenta previa
Beyond the preview
Go deeper on 2023-507763-18-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507763-18-01.